Abu Ali ibn Sino nomidagi Buxoro Davlat tibbiyot instituti

• 
  Dastlabki tashxis ________________________________________________________________
  

____________________________________________________________________________________

• 
  Asorati: _______________________________________________________________________
  

XIII. Tekshiruvlar rejasi:

Tekshiruvlar ro’yxati

Umumiy qon analizi. Umumiy siydik analizi. Balg‘am taxlili. Bioximik qon analizi: bilirubin, ALT, AST, um. oqsil, qand, kreatinin, mochevina. Koagulogramma EKG. Ko‘krak qafasi rentgenografiyasi.

XIV. Laboratoriya va instrumental tekshirish natijalari:

• 
  Umumiy qon taxlili:
  

№	Testlar						normada		tekshiruvda		davolash davomida
1	Ertirotsit			ayol		3,8-4,5*10^12/l
				erkak		4,5-5,0*10^12/l
2	Gemoglobin		ayol				120-140g/l
			erkak				120-160g/l
3	Rang ko‘rsatkich						0,9-1,0
4	Trombotsit						180,0-320,0*10^9/l
5	Leykotsit						4,0-9,0*10^9/l
6	Neytrofil				t/ya		1-6 %
					s/ya		47-72 %
7	Eozinofil						0,5-5 %
8	Monotsit						3-11 %
9	Limfotsit						19-37
10	ECHT	ayol				2-15 mm/soat
		erkak				1-10 mm/soat

• 
  Siydik analizi:
  

Testlar	normada	tekshiruvda	davolash davomida
Rangi	somon rangli
Sol.og‘irligi	1018-1025
Reaksiya	kislotali
Tiniqligi	tiniq
Oqsil	aniqlanmaydi
Qand	aniqlanmaydi
O‘t pigmenti	aniqlanmaydi
Epitelial xujayralar	2-4 ko‘ruv maydonida
Eritrotsit	0-1 ko‘ruv maydonida
Leykotsit	1-3 ko‘ruv maydonida

• 
  Balg’am taxlili:
  

Testlar	normada	tekshiruvda	davolash davomida
Mikdori ml	-
Rangi	-
Xidi	-
Xarakteri	-
	-
Mikroskopiya:	-
Epiteliy	-
Leykotsitlar	-
Eozinofil	-

• 
  Qonning bioximik taxlili:
  

№	Testlar	normada	tekshiruvda	davolash davomida
1	Bilirubin: umumiy erkin bog‘langan	8,5-20,3 mkmol/l 1,7-16,5 mkmol/l 0-5,1 mkmol/l
2	Kreatinin: umumiy ayol erkak	50-115 mkmol/l 53-97 mkmol/l 62-115 mkmol/l
3	Mochevina	4,2-8,3 mmol/l
4	Oqsil fraksiyalari: Umumiy oqsil Albumin Globulin: α1-globulin α2-globulin β-globulin γ-globulin	100 % 56-66,5 % 2,5-5,0 % 5,1-9,2 % 8,1-12,2 % 12,8-19,0 %
	Glyukoza	3,0-6,1 mmol/l
	ALT AST	0,1-0,68 mmol/l 0,1-0,45 mmol/l

• 
  Koagulogramma:
  

Ko‘rsatkich	normada	tekshiruvda	davolash davomida
Gematokrit soni Trombotest Plazmaning geparinga tolerantligi Fibrinogen Trombin indeks Etalon testi	49-58% erkaklarda 38-42% ayollarda V st 37 300-400 mg/% 70-100 % manfiy

• 
  EKG:
  

_____________________________________________________________________________________

_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

Xulosa:___________________________________________________________________________________________________________________________________________________________________

Ko‘krak qafasi rentgenografiyasi :

_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

Xulosa:__________________________________________________________________________

XV. Klinik diagnoz va uni asoslash.

Dastlabki taxminiy diagnoz va klinik-laborator va instrumental tekshiruv. Gemoglobin – ____g/l., Eritrotsitlar –_______¹²/l., Leykotsitlar –_______⁹/l., Eozinofillar –___%. Limfotsitlar –____%.Monotsitlar – __%.Eritrotsitlarning cho’kish tezligi –____mm/soat. Rangli ko’rsatkich – ____; Balg’am taxlili: _____________________________mikroskopiya: Epiteliy ____%, Leykotsitlar –______%, Eozinofil –____% ; Glyukoza –_____mmol/l. Qon bioximiyasi: Umumiy oqsil –____g/l.ALT – ____mmol/l, AST –____ mmol/l, Kreatinin – ____ mmol/l, Mochevina – ____mmol/l, Bilirubin: - umumiy –______mkmol/l.

UZI: Xulosa:________________________________________________________________________ EKG: Xulosa: ______________________________________________________________________

Ko’krak qafasi rentgenografiyasi Xulosa: __________________________________________________

__________________________________________________________________________________________________________________________________________________________________________ natijalariga asoslangan xolda quyidagi klinik diagnoz qo’yildi:
Klinik tashxis:

• 
  Asosiy diagnoz – _______________________________________________________________
  

____________________________________________________________________________________

• 
  Asorati -_______________________________________________________________________
  
• 
  Yondosh diagnoz – _______________________________________________________________
  

Differensial diagnostika:

______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

Davolash
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

Adabiyot qismi:

___________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________